Results 41 to 50 of about 166,616,203 (205)

PANoptosis in the pathogenesis of myelodysplastic syndromes

Molecular Oncology, EarlyView.
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla, Jyoti Lamichhane, Cameron Lewis, Peter Breslin, Jiwang Zhang   +4 more
wiley   +1 more source

Goodness-of-fit test for BTC/HKD.

, 2019
Goodness-of-fit test for BTC/HKD.
Mario I. Contreras-Valdez (6499304), Carlos A. Franco-Ruiz (6499307), José Antonio Núñez (6499301)   +2 more
core   +1 more source

Goodness-of-fit.

, 2022
Goodness-of-fit.
Arnaldo Vergara-Romero (12102322), Juan Antonio Jimber del Río (12102328), José Fernando Romero Subia (12102325), María Salomé Ochoa Rico (12102319)   +3 more
core   +1 more source

Partial FAK suppression promotes tumor growth, an effect reversed by macrophage p110δ PI3K inactivation

Molecular Oncology, EarlyView.
Partial inhibition of focal adhesion kinase (FAK) can paradoxically promote tumor growth, rather than simply producing a weaker antitumor effect than that observed with strong FAK suppression. In breast cancer and melanoma models, targeting p110δ PI3K, particularly in macrophages, counteracted these tumor‐promoting effects, highlighting the importance ...
Lydia Xenou, Niki Tzenaki, Anna Tsapara, Maria Tzardi, Evangelia A. Papakonstanti   +4 more
wiley   +1 more source

Goodness-of-fit test for BTC/BRL.

, 2019
Goodness-of-fit test for BTC/BRL.
Mario I. Contreras-Valdez (6499304), Carlos A. Franco-Ruiz (6499307), José Antonio Núñez (6499301)   +2 more
core   +1 more source

Profiling neoadjuvant therapy response in rectal cancer using meta‐analysis of publicly available transcriptomic RNA‐seq datasets

Molecular Oncology, EarlyView.
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic, Rafael Stroggilos, Mladen Marinkovic, Ana Djuric, Suzana Stojanovic‐Rundic, Radmila Jankovic, Sergi Castellvi‐Bel, Remond J.A. Fijneman, Antonia Vlahou, Jerome Zoidakis, Milena Cavic   +10 more
wiley   +1 more source

Goodness-of-fit test for BTC/USD.

, 2019
Goodness-of-fit test for BTC/USD.
Mario I. Contreras-Valdez (6499304), Carlos A. Franco-Ruiz (6499307), José Antonio Núñez (6499301)   +2 more
core   +1 more source

Goodness-of-fit measure.

, 2022
Goodness-of-fit measure.
Sadia Choudhury Shimmi (10833707), Hasanur Bin Khazri (13531609), M. Tanveer Hossain Parash (10833698)   +2 more
core   +1 more source

Gut microbiota alterations in patients with non‐small‐cell lung cancer undergoing chemoradiotherapy

Molecular Oncology, EarlyView.
We investigated the impact of concurrent chemoradiotherapy (CRT) on the gut microbiota in patients with locally advanced non‐small‐cell lung cancer. Overall gut microbiota composition remained largely stable throughout CRT while antibiotic exposure may influence microbial diversity.
Hanne Marte Nymoen, Zhi Zhao, Henrik Horndalsveen, Maria Moksnes Bjaanæs, Bjørn Henning Grønberg, Tarje Halvorsen, Tesfaye Madebo, Marianne Aanerud, Jussi Koivunen, Kersti Oselin, Saulius Cicenas, Nina Helbekkmo, Jarkko Ahvonen, Maria Silvoniemi, Tine Norman Alver, Tonje Dalen, Åsa Kristina Öjlert, Saima Jamil Farooqi, Åslaug Helland, Vilde Drageset Haakensen   +19 more
wiley   +1 more source

Goodness-of-fit test for BTC/EUR.

, 2019
Goodness-of-fit test for BTC/EUR.
Mario I. Contreras-Valdez (6499304), Carlos A. Franco-Ruiz (6499307), José Antonio Núñez (6499301)   +2 more
core   +1 more source